Cronos Group Inc banner

Cronos Group Inc
TSX:CRON

Watchlist Manager
Cronos Group Inc Logo
Cronos Group Inc
TSX:CRON
Watchlist
Price: 3.75 CAD -0.79%
Market Cap: CA$1.4B

CRON's latest stock split occurred on Dec 17, 2014

The company executed a 1-for-7 stock split, meaning that for every 7 shares held, investors received 1 new share.

The adjusted shares began trading on Dec 17, 2014. This was the only stock split in CRON's history.

Last Splits:
Dec 17, 2014
1-for-7
Pre-Split Price
N/A
Post-Split Price
0.8
Before
After
Last Splits:
Dec 17, 2014
1-for-7

Cronos Group Inc
Stock Splits History

CRON Stock Splits Timeline
Dec 17, 2014
Dec 17, 2014
Split 1-for-7
/0.14285714285714
Pre-Split Price
N/A
Post-Split Price
0.8
Before
After

Global
Stock Splits Monitor

Date Company Split Pre-Split Price Post-Split Price
Apr 22, 2026
Chimeric Therapeutics Ltd
ASX:CHM
1-for-100
/100
0.002 0.2 AUD 0.17 0.17 AUD
Apr 22, 2026
Architects Studio Japan Inc
TSE:6085
10-for-1
x10
3800 380 JPY 430 430 JPY
Apr 22, 2026
Freewon China Co Ltd
SSE:688678
1-for-1
x1
30.5 21.6857 CNY 23.64 23.64 CNY
Apr 22, 2026
S
Sharetronic Data Technology Co Ltd
SZSE:300857
1-for-1
x1
304.5701 217.2101 CNY 260.76 260.76 CNY
Apr 21, 2026
Canon Electronics Inc
OTC:CAOEF
1-for-6235122
/6235122
16.96 16.96 USD N/A
Load More

Cronos Group Inc
Glance View

Market Cap
1.4B CAD
Industry
Pharmaceuticals

Cronos Group, Inc. engages in the production and distribution of cannabis. The company is headquartered in Toronto, Ontario. The company went IPO on 2014-05-07. The firm is focused on cannabis research, technology and product development. The Company’s portfolio includes PEACE NATURALS, COVE, Spinach, Lord Jones, Happy Dance and PEACE+. PEACE NATURALS a global wellness platform. The COVE and Spinach are adult-use brands. The Lord Jones, Happy Dance and PEACE+ are hemp-derived cannabidiol (CBD) brands. The Company’s segments include United States and Rest of World. The United States operating segment consists of the manufacture and distribution of hemp-derived CBD infused products. The Rest of World operating segment is involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. The Company’s subsidiaries include Cronos Israel G.S. Cultivation Ltd, Cronos Israel G.S. Manufacturing Ltd., Cronos Israel G.S. Store Ltd. and Cronos Israel G.S. Pharmacy Ltd.

CRON Intrinsic Value
1.91 CAD
Overvaluation 49%
Intrinsic Value
Price CA$3.75
Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett